CN1114595C - 制备异硫氰酸吡啶基甲酯的方法 - Google Patents

制备异硫氰酸吡啶基甲酯的方法 Download PDF

Info

Publication number
CN1114595C
CN1114595C CN98116170A CN98116170A CN1114595C CN 1114595 C CN1114595 C CN 1114595C CN 98116170 A CN98116170 A CN 98116170A CN 98116170 A CN98116170 A CN 98116170A CN 1114595 C CN1114595 C CN 1114595C
Authority
CN
China
Prior art keywords
formula
reaction
general formula
iii
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN98116170A
Other languages
English (en)
Other versions
CN1206709A (zh
Inventor
K·瓦格纳
R·岚茨施
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of CN1206709A publication Critical patent/CN1206709A/zh
Application granted granted Critical
Publication of CN1114595C publication Critical patent/CN1114595C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40Acylated substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C329/00Thiocarbonic acids; Halides, esters or anhydrides thereof
    • C07C329/12Dithiocarbonic acids; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Detergent Compositions (AREA)

Abstract

本发明涉及一种新的制备通式(I)所示异硫氰酸吡啶基甲酯的方法,其特征在于,第一步反应中,通式(II)所示的胺与通式(II)所示黄原酸盐,如果适宜的话在稀释剂存在下,反应,及第二步反应中,所得通式(IV)所示的新的二硫代氨基甲酸盐,如果适宜的话在稀释剂存在下,氧化,制得通式(I)的异硫氰酸盐化合物,其中,R1代表卤素或C1-C4-烷基,其中,R1如上所述,其中,R2代表C1-C4-烷基,优选甲基或乙基及M代表碱金属优选钠和钾或代表铵,其中,R1和M分别如上所述。

Description

制备异硫氰酸吡啶基甲酯的方法
技术领域
本发明涉及一种新的制备异硫氰酸吡啶基甲酯的方法及其新中间体。
背景技术
现有制备异硫氰酸吡啶基甲酯的方法是将通式(A)所示吡啶基甲基胺与二硫化碳和例如氯甲酸乙酯在碱如氢氧化钠存在的条件下按下列反应式进行反应:
            1)CS2
            2)ClCOOC2H5
Py-CH2-NH2→Py-CH2-NCS
   (A)      碱
Py=选择性取代的吡啶基,例如2-氯-5-吡啶基(参见EP-A0 302 389)
然而,上述方法的不利之处在于选用二硫化碳作为反应参与物。此外还会生成氧硫化碳副产物。
发明内容
现已发现制备具有良好产率和高纯度通式(I)所示异硫氰酸吡啶基甲酯的方法,
Figure C9811617000051
其中,R1代表卤素或C1-C4-烷基,
第一步反应中,通式(II)所示的胺与通式(III)所示黄原酸盐,如果适宜的话在稀释剂存在下,反应,
其中,R1如上所述,
        R2O-CS-SM      (III)
其中,
R2代表C1-C4-烷基,优选甲基或乙基,及
M代表碱金属,优选钠和钾,或代表铵,及
第二步反应中,所得通式(IV)所示的二硫代氨基甲酸盐,如果适宜的话在稀释剂存在下,氧化,制得通式(I)的异硫氰酸化合物,
Figure C9811617000061
其中,
R1和M分别如上所述。
式(I)为本发明制得的异硫氰酸吡啶基甲酯化合物的通式。此通式中,R1优选为氯或甲基。
令人惊奇地是,式(I)所示异硫氰酸吡啶基甲酯在本发明制备方法中收率良好并且纯度较高,尽管式(III)黄原酸盐中的含硫基团MSH是比醇基团R2OH更好的离去基团,而该反应机制因此本应推断为:
Figure C9811617000062
本发明所述制备反应的优越性在于不采用二硫化碳作为反应参与物。此外,反应情况简单(无放热反应)并且反应过程中无副反应。
反应中采用例如5-氨基甲基-2-氯吡啶和乙基黄原酸钾作为起始反应物并以NaOCl水溶液作为氧化剂,本发明所述方法的反应过程如下列反应式所示:
作为本发明所述方法第一步反应中的起始反应物的式(II)所示胺化合物是已知的(参见,例如EP-A 0 391 205或US-P 4 499 097)和/或可通过常规方法制得。
作为本发明方法第一步反应的另一起始反应物的式(III)所示黄原酸盐也是公知化合物。
式(IV)代表本发明所述制备方法第一步反应的产物二硫代氨基甲酸盐的结构通式。此通式中,R1优选为氯或甲基并且M优选为钠,钾或铵。
式(IV)的二硫代氨基甲酸盐是新化合物并且也是本申请的发明主题之一。
本发明所述方法的第二步反应的优选氧化剂是:次氯酸钠或次氯酸钾溶液和铜(II)化合物例如硫酸铜。
本发明所述方法中第一步反应的适宜稀释剂是常规有机溶剂。其中优选烃类,例如甲苯或二甲苯;醚,例如甲基叔丁基醚、甲基叔戊基醚、1,2-二甲氧基乙烷、1,2-二乙氧基乙烷、四氢呋喃或二噁烷;醇,例如甲醇、乙醇、正丙醇、异丙醇、正-、异-、仲-或叔-丁醇;腈,例如乙腈、丙腈或丁腈;以及酰胺,例如二甲基甲酰胺。
进行本发明方法第一步时的反应温度可在相对较宽的范围内变化。通常,反应温度介于30-150℃之间,优选介于50-120℃之间。
在本发明所述方法第一步反应中优选采用等摩尔量反应。然而,反应亦允许价廉的式(III)所示黄原酸盐有相对较大的过量,优选过量100%。
反应结束后生成新的式(IV)所示二硫代氨基甲酸盐并且可用常规方法分离出该化合物(参见:制备实施例)。
本发明所述方法的第二步氧化反应的优选稀释剂是水和另一惰性微水溶的溶剂,例如烃类、氯代烃、醚、腈、酮或酰胺。
本发明所述方法第二步中的反应温度可在相对较宽范围内变化。通常,反应温度介于-30℃-50℃之间,优选介于-10℃-10℃之间。
以每摩尔二硫代氨基甲酸盐计,本发明所述方法第二步反应中所用氧化剂通常是4-5摩尔,优选4-4.5摩尔。
反应结束后得到式(I)的异硫氰酸吡啶基甲酯并且可用常规方法将其分离(参见:制备实施例)。
通过本发明所述制备方法制得的式(I)异硫氰酸吡啶基甲酯可作为制备生物活性化合物例如杀虫剂的中间体(参见:例如EP-A 0 302389)。
具体实施方式
制备实施例
实施例1
(第二步反应)
将51.3g(0.2mol)的2-氯-5-吡啶基甲基二硫代氨基甲酸钾(参见:第一步反应)溶解在200ml水中并再混入200ml的二氯甲烷。
在0℃下,将460ml浓度为13%的NaOCl水溶液维持反应温度不超过5℃滴加到上述溶液中。反应混合物在0-5℃下搅拌30分钟,然后分离出有机相,水相用二氯甲烷萃取三次,合并有机相并用硫酸钠干燥。
蒸除溶剂,在冰箱内结晶出31.3g(为理论产率的82%)的2-氯-5-吡啶基甲基异硫氰酸酯(熔点:22℃)。
(第一步反应)
将2.85g(20mmol)2-氯-5-氨基甲基-吡啶和3.2g(20mmol)乙基黄原酸钾在30ml乙醇中搅拌下回流过夜。
冷却并过滤反应混合物:得到4.4g(为理论产率的86%)熔点为252℃(分解)的2-氯-5-吡啶基甲基二硫代氨基甲酸钾。

Claims (4)

1.一种通式(I)所示异硫氰酸吡啶基甲酯的制备方法
Figure C9811617000021
其中,R1代表卤素或C1-C4-烷基,
其特征在于:
第一步反应中,通式(II)所示的胺与通式(III)所示黄原酸盐在稀释剂存在下并在30℃至150℃温度下进行反应,
Figure C9811617000022
其中,R1如上所述,
R2O-CS-SΘM         (III)
其中,
R2代表C1-C4-烷基,及
M代表碱金属或铵,
第二步反应中,所得通式(IV)所示的二硫代氨基甲酸盐在稀释剂存在下并在-30℃至50℃温度下进行氧化而得到通式(I)的异硫氰酸盐化合物,
其中,
R1和M分别如上所述。
2.通式(IV)所示的二硫代氨基甲酸盐
Figure C9811617000031
其中,
R1代表卤素或C1-C4-烷基,及
M代表碱金属或铵。
3.通式(IV)所示二硫代氨基甲酸盐的制备方法,
Figure C9811617000032
其中,
R1和M分别如权利要求1所述,
其特征在于,式(II)所示的胺与式(III)所示黄原酸盐在稀释剂存在下并在30℃至150℃温度下进行反应,
Figure C9811617000033
其中,R1如权利要求1所述,
 R2O-CS-SΘM         (III)
其中,
R2代表C1-C4-烷基,及
M代表碱金属或铵。
4.通式(IV)所示二硫代氨基甲酸盐在制备通式(I)所示异硫氰酸吡啶基甲酯中的应用,
Figure C9811617000041
其中,R1和M分别如权利要求2所述,
Figure C9811617000042
其中,R1代表卤素或C1-C4-烷基。
CN98116170A 1997-07-24 1998-07-24 制备异硫氰酸吡啶基甲酯的方法 Expired - Fee Related CN1114595C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19731782.0 1997-07-24
DE19731782A DE19731782A1 (de) 1997-07-24 1997-07-24 Verfahren zur Herstellung von Pyridylmethylisocyanaten

Publications (2)

Publication Number Publication Date
CN1206709A CN1206709A (zh) 1999-02-03
CN1114595C true CN1114595C (zh) 2003-07-16

Family

ID=7836723

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98116170A Expired - Fee Related CN1114595C (zh) 1997-07-24 1998-07-24 制备异硫氰酸吡啶基甲酯的方法

Country Status (9)

Country Link
US (2) US5936093A (zh)
EP (1) EP0893441B1 (zh)
JP (1) JP4338237B2 (zh)
KR (1) KR100499901B1 (zh)
CN (1) CN1114595C (zh)
DE (2) DE19731782A1 (zh)
DK (1) DK0893441T3 (zh)
ES (1) ES2186057T3 (zh)
HK (1) HK1018262A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101735128B (zh) * 2009-12-31 2013-11-20 北京农鹰现代农业技术研究院 制取异硫氰酸烯丙酯的方法
CN102229551B (zh) * 2011-04-29 2014-07-02 浙江工业大学 一种异硫氰酸酯的制备方法
CN102993073A (zh) * 2012-03-27 2013-03-27 中国农业科学院兰州畜牧与兽药研究所 异硫氰酸2,6-二甲基苯酯的制备方法
CN103012226B (zh) * 2012-12-27 2014-11-19 济南圣泉唐和唐生物科技有限公司 一种异硫氰酸乙酯的制备方法
CN103086933B (zh) * 2013-01-23 2014-07-02 安徽工程大学 一种苯基异硫氰酸酯的制备方法
CN112979632B (zh) * 2021-03-15 2022-08-30 台州学院 一种4-羟基-1,3-噻嗪-2-硫酮类化合物的合成方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4129656A (en) * 1976-01-20 1978-12-12 Hoechst Aktiengesellschaft Thiazolidine derivatives, salidiuretic compositions and methods of effecting salidiuresis employing them
EP0302389A2 (en) * 1987-08-01 1989-02-08 Takeda Chemical Industries, Ltd. Alpha-unsaturated amines, their production and use

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4129656A (en) * 1976-01-20 1978-12-12 Hoechst Aktiengesellschaft Thiazolidine derivatives, salidiuretic compositions and methods of effecting salidiuresis employing them
EP0302389A2 (en) * 1987-08-01 1989-02-08 Takeda Chemical Industries, Ltd. Alpha-unsaturated amines, their production and use
US5175301A (en) * 1987-08-01 1992-12-29 Takeda Chemical Industries, Ltd. Alpha-unsaturated amine pyridine compounds

Also Published As

Publication number Publication date
DE59806793D1 (de) 2003-02-06
EP0893441A1 (de) 1999-01-27
JPH1192453A (ja) 1999-04-06
DE19731782A1 (de) 1999-01-28
DK0893441T3 (da) 2003-03-24
JP4338237B2 (ja) 2009-10-07
CN1206709A (zh) 1999-02-03
ES2186057T3 (es) 2003-05-01
KR100499901B1 (ko) 2006-04-12
US5936093A (en) 1999-08-10
HK1018262A1 (en) 1999-12-17
US6166214A (en) 2000-12-26
EP0893441B1 (de) 2003-01-02
KR19990013838A (ko) 1999-02-25

Similar Documents

Publication Publication Date Title
CN1114595C (zh) 制备异硫氰酸吡啶基甲酯的方法
KR20050057057A (ko) 나프록센의 니트로옥시유도체 제조방법
JPH0892202A (ja) チオアミドの製造方法
JP3810108B2 (ja) シアノイミノ−1,3−チアゾリジン類の製造方法
EP0873327A1 (en) Process for the preparation of 2-chloro-5-chloromethyl-thiazole
JP4407062B2 (ja) ジフェニルジスルフィド誘導体の製造法
CN114853648B (zh) 一种nbs促进硫醚c-s键断裂制备非对称二硫醚的方法
WO1997023469A9 (en) Process for the preparation of 2-chloro-5-chloromethyl-thiazole
KR910014353A (ko) 2-클로로-5-메틸-피리딘의 제조방법
JPS58124764A (ja) 光学活性チオ−ル化合物の製造法
US6506904B1 (en) Method of preparing N,N′-disubstituted-3,3′-dithiodipropionamide and method of preparing substituted 3-isothiazolone by using the same
US3637788A (en) Process for producing isothiocyanates
CN113121395B (zh) 单官能秋兰姆促进剂的合成
US6184412B1 (en) Process for manufacture of N-alkoxy(or aryloxy)carbonyl isothiocyanate derivatives in the presence of N,N-dialkylarylamine catalyst and aqueous solvent
JP4465674B2 (ja) ベンジル(ジフルオロメチル)スルフィド化合物の製造方法
MXPA98005934A (en) Procedure for the obtaining of piridilmetilisotiociana
KR100634076B1 (ko) 티올카르바메이트 및 티오시아네이트 화합물의 제조방법
JPS6130576A (ja) 2−アミノ−5−シアノピリミジンの製法
US4234514A (en) Method of preparing ketoxime carbamates
KR100518933B1 (ko) 옥사졸린-아제티디논 유도체의 정제방법
KR960010100B1 (ko) 2-메틸디티오카바즈산 에스테르의 제조방법
JPH0253764A (ja) ジチオビスフェノールの製造方法
JPH053872B2 (zh)
JPS63119454A (ja) 新規なα−クロロケトン誘導体および製造法
WO2001012594A1 (fr) Procede de preparation de chlorures de sulfenyle aromatiques et autres

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: BAYER INTELLECTUAL PROPERTY GMBH

Free format text: FORMER OWNER: BAYER AKTIENGESELLSCHAFT

Effective date: 20150609

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20150609

Address after: German Monheim

Patentee after: Bayer Pharma Aktiengesellschaft

Address before: Germany Leverkusen

Patentee before: Bayer Aktiengesellschaft

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20030716

Termination date: 20150724

EXPY Termination of patent right or utility model